Works matching IS 18696953 AND DT 2022 AND VI 13 AND IP 5
Results: 22
Observational Study on Unhealthy Eating Behavior and the Effect of Sodium-Glucose Cotransporter 2 Inhibitors: The Luseogliflozin Ehime Diabetes Study.
- Published in:
- Diabetes Therapy, 2022, v. 13, n. 5, p. 1073, doi. 10.1007/s13300-022-01261-9
- By:
- Publication type:
- Article
Mortality in People with Type 2 Diabetes Following SARS-CoV-2 Infection: A Population Level Analysis of Potential Risk Factors.
- Published in:
- Diabetes Therapy, 2022, v. 13, n. 5, p. 1037, doi. 10.1007/s13300-022-01259-3
- By:
- Publication type:
- Article
The Emerging Role of Continuous Glucose Monitoring in the Management of Diabetic Peripheral Neuropathy: A Narrative Review.
- Published in:
- Diabetes Therapy, 2022, v. 13, n. 5, p. 931, doi. 10.1007/s13300-022-01257-5
- By:
- Publication type:
- Article
Testosterone Deficiency is Not Protective Against the Development of Adenocarcinoma of the Prostate in a Type 1 Diabetic Patient.
- Published in:
- Diabetes Therapy, 2022, v. 13, n. 5, p. 1115, doi. 10.1007/s13300-022-01256-6
- By:
- Publication type:
- Article
Biosimilar Insulin Aspart Premix SAR341402 Mix 70/30 Versus Originator Insulin Aspart Mix 70/30 (NovoMix 30) in People with Diabetes: A 26-Week, Randomized, Open-Label Trial (GEMELLI M).
- Published in:
- Diabetes Therapy, 2022, v. 13, n. 5, p. 1053, doi. 10.1007/s13300-022-01255-7
- By:
- Publication type:
- Article
Self-Monitoring of Blood Glucose as an Integral Part in the Management of People with Type 2 Diabetes Mellitus.
- Published in:
- Diabetes Therapy, 2022, v. 13, n. 5, p. 829, doi. 10.1007/s13300-022-01254-8
- By:
- Publication type:
- Article
A Response to: Letter to the Editor with Regard to the Cost-Effectiveness of an Advanced Hybrid Closed-Loop System in People with Type 1 Diabetes: A Health Economic Analysis in Sweden.
- Published in:
- 2022
- By:
- Publication type:
- Letter
Cost-Effectiveness of Intermittently Scanned Continuous Glucose Monitoring Versus Advanced Hybrid Closed-Loop Systems in Type 1 Diabetes: Comment on Jendle et al.
- Published in:
- 2022
- By:
- Publication type:
- Letter
Effects of Pentoxifylline on Serum Markers of Diabetic Nephropathy in Type 2 Diabetes.
- Published in:
- Diabetes Therapy, 2022, v. 13, n. 5, p. 1023, doi. 10.1007/s13300-022-01250-y
- By:
- Publication type:
- Article
The FIDELIO Study Podcast.
- Published in:
- Diabetes Therapy, 2022, v. 13, n. 5, p. 823, doi. 10.1007/s13300-022-01249-5
- By:
- Publication type:
- Article
Correction to: Cost-Effectiveness Evaluation of a Remote Monitoring Programme Including Lifestyle Education Software in Type 2 Diabetes: Results of the Educ@dom Study.
- Published in:
- 2022
- By:
- Publication type:
- Correction Notice
Clinical Use of Insulin Glargine 300 U/mL in Adults with Type 2 Diabetes: Hypothetical Case Studies.
- Published in:
- Diabetes Therapy, 2022, v. 13, n. 5, p. 913, doi. 10.1007/s13300-022-01247-7
- By:
- Publication type:
- Article
A Therapeutic Vibrating Insole Device for Postural Instability in Older People with Type 2 Diabetes: A Randomized Control Study.
- Published in:
- Diabetes Therapy, 2022, v. 13, n. 5, p. 995, doi. 10.1007/s13300-022-01246-8
- By:
- Publication type:
- Article
Impact of My Dose Coach App Frequency of Use on Clinical Outcomes in Type 2 Diabetes.
- Published in:
- Diabetes Therapy, 2022, v. 13, n. 5, p. 983, doi. 10.1007/s13300-022-01245-9
- By:
- Publication type:
- Article
The Prevalence of Cardiovascular Disease in Adults with Type 2 Diabetes in China: Results from the Cross-Sectional CAPTURE Study.
- Published in:
- Diabetes Therapy, 2022, v. 13, n. 5, p. 969, doi. 10.1007/s13300-022-01243-x
- By:
- Publication type:
- Article
Defining the Role of SGLT2 Inhibitors in Primary Care: Time to Think Differently.
- Published in:
- Diabetes Therapy, 2022, v. 13, n. 5, p. 889, doi. 10.1007/s13300-022-01242-y
- By:
- Publication type:
- Article
Level of Agreement and Correlation Between the Estimated Hemoglobin A1c Results Derived by Continuous or Conventional Glucose Monitoring Systems Compared with the Point-of-Care or Laboratory-Based Measurements: An Observational Study.
- Published in:
- Diabetes Therapy, 2022, v. 13, n. 5, p. 953, doi. 10.1007/s13300-022-01240-0
- By:
- Publication type:
- Article
Additional Effect of Luseogliflozin on Semaglutide in Nonalcoholic Steatohepatitis Complicated by Type 2 Diabetes Mellitus: An Open-Label, Randomized, Parallel-Group Study.
- Published in:
- Diabetes Therapy, 2022, v. 13, n. 5, p. 1083, doi. 10.1007/s13300-022-01239-7
- By:
- Publication type:
- Article
Beyond the Glycaemic Control of Dapagliflozin: Microangiopathy and Non-classical Complications.
- Published in:
- Diabetes Therapy, 2022, v. 13, n. 5, p. 873, doi. 10.1007/s13300-022-01237-9
- By:
- Publication type:
- Article
The Risk Factors Potentially Influencing Hospital Admission in People with Diabetes, Following SARS-CoV-2 Infection: A Population-Level Analysis.
- Published in:
- Diabetes Therapy, 2022, v. 13, n. 5, p. 1007, doi. 10.1007/s13300-022-01230-2
- By:
- Publication type:
- Article
The Place and Value of Sodium-Glucose Cotransporter 2 Inhibitors in the Evolving Treatment Paradigm for Type 2 Diabetes Mellitus: A Narrative Review.
- Published in:
- Diabetes Therapy, 2022, v. 13, n. 5, p. 847, doi. 10.1007/s13300-022-01228-w
- By:
- Publication type:
- Article
Expert Opinion: Optimum Clinical Approach to Combination-Use of SGLT2i + DPP4i in the Indian Diabetes Setting.
- Published in:
- Diabetes Therapy, 2022, v. 13, n. 5, p. 1097, doi. 10.1007/s13300-022-01219-x
- By:
- Publication type:
- Article